AnalyzeDirect

Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, Schapiro MB, Möller HJ, Rapoport SI, Hampel H. Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol. February 2002;59(2):243-248.

Full Text – Open Access

Publication Date
February 2002

How Analyze was Used
“Preprocessing and subsequent measurements were done using ANALYZE software … on an SGI workstation.”

Keywords
Aged
Alzheimer Disease/complications
Atrophy
Biological Markers
Corpus Callosum/pathology
Cross-Sectional Studies
Disease Progression
Female
Humans
Male
Severity of Illness Index

Author Affiliation(s)
Dementia and Neuroimaging Section, Department of Psychiatry, Ludwig-Maximilian University, Munich, Germany. (SJT, WB, YZ, LK, HJM, HH)

Arizona Alzheimer’s Research Center and Department of Psychology, Arizona State University, Tempe, AZ, US. (GEA)

Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD, US. (DT, SIR)

Department of Pediatric Neurology, Children Hospital Medical Center, Cincinnati, OH, US. (MBS)

ID# 2533

Tags: Aged, Alzheimer Disease/complications, Atrophy, Biological Markers, Corpus Callosum/pathology, Cross Sectional Studies, Disease Progression, Female, Humans, Male, Severity of Illness Index